Stocks Up After Earnings (MetLife, Inc., NCR, LXK)


MetLife, Inc.  (NYSE:MET) shares climbed 2.35% to $36.51, off day’s high of $37.40 following the company said that it earned $3.55 billion, or $3.33 a share due to revenue generated by an international acquisition, compared to a year ago profit of $286 million, or 32 a share. Operating profit came at $1.11 a share, beating analyst’ estimates by 5 cents.

NCR Corporation  (NYSE:NCR)  added 35 cents or 1.79% to $19.95 after the company said that it earned 53 cents a share on revenue of $1.4 billion, well ahead of analysts’ estimates of 47 cents a share on revenue of $1.37 billion.

For the FY2011, the company lifted its guidance to $1.79-$1.83, from its earlier guidance of $1.73-$1.80, topping analsysts’ estimates of $1.82 a share.

Lexmark International, Inc.  (NYSE:LXK) soared $1.26 or 4.01% to $32.69 after the company said that it earbed $67 million, or 86 cents a share on revenue of $1.03 billion, compared to a year ago profit of $72 million, or 90 cents a share.

On an adjusted basis, the company earned  95 cents a share, compared to its own guidance of 94 cents to $1.04 a share with revenue flat to down.

For the current quarter, the company expects to earn $1.15 to $1.25, ahead of analysts’ estimates of $1.13 a share. The company expects revenue to decline in the mid-single digit range year on year, compared with a 4% decline expected by Wall Street.

Disclaimer:

The assembled information distributed by headlineotc.com is for information purposes only, and is neither a solicitation to buy nor an offer to sell securities. Headlineotc.com does expect that investors will buy and sell securities based on information assembled and presented herein. Headlineotc.com will not be responsible in any way for or accept any liability for any losses arising from an investor’s reliance on or use of information obtained from our website or emails. PLEASE always do your own due diligence, and consult your financial advisor.

Tagged with: | | | | | |
Our Research Report on MET is now available. Don´t Trade MET until you Read our FREE FULL REPORT. Click Here